We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

56 hedge funds and large institutions have $62.8M invested in Corcept Therapeutics in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

36.34% more ownership

Funds ownership: 0% → 36.34% (+36%)

56% less call options, than puts

Call options by funds: $75K | Put options by funds: $172K

Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
56
Increased
–
Reduced
–
Closed
–
Calls
$75K
Puts
$172K
Net Calls
-$97K
Net Calls Change
-$97K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

CORT Hedge Fund Activity: Q2 2013 in Review

56 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q2 2013, worth a combined $62.8M.

Buyers outnumbered sellers: 56 funds opened new CORT positions and 0 closed out — a net gain of 56 holders — while 0 added to existing stakes and 0 trimmed.

  • 56 institutional investors held Corcept Therapeutics (CORT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $62.8M of Corcept Therapeutics stock for Q2 2013.
  • 56 funds opened new Corcept Therapeutics positions in Q2 2013 and 0 closed out, a net change of +56 holders.

Based on aggregated 13F filings for Q2 2013.